Treatment effects between monotherapy of donepezil versus combination with memantine for Alzheimer disease: A meta-analysis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment effects between monotherapy of donepezil versus combination with memantine for Alzheimer disease: A meta-analysis
Authors
Keywords
Alzheimers disease, Adverse reactions, Drug therapy, Meta-analysis, Receptor antagonist therapy, Dementia, Neurological drug therapy, Database searching
Journal
PLoS One
Volume 12, Issue 8, Pages e0183586
Publisher
Public Library of Science (PLoS)
Online
2017-08-22
DOI
10.1371/journal.pone.0183586
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current Practices in the Treatment of Alzheimer Disease: Where is the Evidence After the Phase III Trials?
- (2015) Megan J. Ehret et al. CLINICAL THERAPEUTICS
- The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer’s Disease
- (2015) William James Deardorff et al. DRUGS & AGING
- A review on Alzheimer's disease pathophysiology and its management: an update
- (2015) Anil Kumar et al. Pharmacological Reports
- The effects of combine treatment of memantine and donepezil on Alzheimer's Disease patients and its relationship with cerebral blood flow in the prefrontal area
- (2014) Tomoko Araki et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline
- (2013) Parminder Raina et al. ANNALS OF INTERNAL MEDICINE
- Efficacy of Memantine, Donepezil, or Their Association in Moderate-Severe Alzheimer’s Disease: A Review of Clinical Trials
- (2013) Ivana Molino et al. TheScientificWorldJOURNAL
- Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer’s disease receiving donepezil
- (2013) Osamu Kano et al. Neuropsychiatric Disease and Treatment
- Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy
- (2013) Alireza Atri et al. Alzheimers Research & Therapy
- Efficacy and Safety of Donepezil 23 mg versus Donepezil 10 mg for Moderate-to-Severe Alzheimers Disease: A Subgroup Analysis in Patients Already Taking or Not Taking Concomitant Memantine
- (2012) Rachelle S. Doody et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Does Pharmacological Treatment of Neuropsychiatric Symptoms in Alzheimerʼs Disease Relieve Caregiver Burden?
- (2012) Karen Levy et al. DRUGS & AGING
- Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
- (2012) Robert Howard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review
- (2012) Lucy E Farrimond et al. BMJ Open
- Memantine Treatment in Patients with Mild to Moderate Alzheimers Disease Already Receiving a Cholinesterase Inhibitor: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2008) Anton Porsteinsson et al. Current Alzheimer Research
- Efficacy of Memantine on Behavioral and Psychological Symptoms Related to Dementia: A Systematic Meta-Analysis
- (2007) Ian D Maidment et al. ANNALS OF PHARMACOTHERAPY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started